Author

Niels Vande Casteele 1

1 KU Leuven,Leuven,Belgium

POINT-OF-CARE ASSAYS FOR RAPID QUANTIFICATION OF INFLIXIMAB

Thomas Van Stappen, Jiadi Lu, Nick Geukens, Dragana Spasic, Filip Delport, Nasim Zali, Yessica Kölmel, Steffen Rameil, Jeroen Lammertyn, Niels Vande Casteele, Ann Gils

REAL-WORLD EXPOSURE-RESPONSE RELATIONSHIP OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A POOLED MULTICENTRE OBSERVATIONAL COHORT ANALYSIS OF CLINICAL AND MODELED PHARMACOLOGICAL DATA

Niels Vande Casteele

REAL-WORLD EXPOSURE-RESPONSE RELATIONSHIP OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A POOLED MULTICENTRE OBSERVATIONAL COHORT ANALYSIS OF CLINICAL AND MODELED PHARMACOLOGICAL DATA

Niels Vande Casteele, William Sandborn, Brian G. Feagan, Severine Vermeire, Parambir Dulai, Julian Panés, Andres Yarur, Xavier Roblin, Shomron Ben-Horin, Iris Dotan, Mark Osterman, Dirk Lindner, Christian Agboton, Maria Rosario, Teresa Osborn

RELATIONSHIP BETWEEN BIOPSY LOCATION, HISTOLOGICAL DISEASE ACTIVITY, AND MRNA EXPRESSION IN ENDOSCOPICALLY ACTIVE CROHN'S DISEASE

Gregor Novak, Toer W. Stevens, Niels Vande Casteele, Peter Bossuyt, Borut Stabuc, Tanja Van Viegen, Jenny Jeyarajah, Ingrid Gaemers, Lisa Shackelton, Reena Khanna, Gijs R. van den Brink, William Sandborn, Brian G. Feagan, Rish K. Pai, Vipul Jairath, Geert R. D'Haens

SELECTING IBD PATIENTS WHO WILL BENEFIT FROM THROMBOPROPHYLAXIS THROUGH A RISK ASSESSMENT THAT INCLUDES CLOT LYSIS PARAMETERS AND CLINICAL ASSESSMENT

Lize Bollen, Niels Vande Casteele, Wouter Van Moerkercke, Marc Ferrante, Severine Vermeire, Ann Gils

Item 1 - 5 / 5
1